Clinical Trial Update: Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation [EARLY_Phase 1]

View source ↗

Summary

This early-phase study reports preliminary data on the efficacy and safety of combining aprepitant with ondansetron and dexamethasone to prevent chemotherapy-in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Ondansetron (ondansetron)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Nausea, Vomiting | EARLY_Phase 1 | Status: COMPLETED